In the high-stakes world of boxing, trust is as fragile as a fighter’s glass jaw, and one misstep can shatter years of reputation. Take the case of Devin Haney and Ryan Garcia, whose rivalry ignited in 2024 but now teeters on the brink of irrelevance—all because of a single, controversial decision. But here’s where it gets complicated: Garcia’s uncharacteristic antics before their title bout—like chugging a ‘beer’ on the scales while weighing in 3.2 lbs over the 140 lb limit—were just the tip of the iceberg. Despite the fight proceeding and Garcia delivering a jaw-dropping majority-decision victory, the aftermath revealed a darker truth: he tested positive for Ostarine, a performance-enhancing drug, leading to a no-contest ruling and a one-year ban. And this is the part most people miss: Haney, once eager for a rematch, has now slammed the door shut—not because of the loss, but because Garcia opted out of year-round VADA drug testing. 'Ship sailed when he dropped outta VADA testing,' Haney bluntly stated on X, drawing a line in the sand. Garcia’s return to the ring, including a recent title shot against Rolando Romero and an upcoming bout with Mario Barrios on February 21, has done little to rebuild Haney’s trust. Here’s the kicker: While Barrios-Garcia headlines a DAZN PPV card with two additional world title fights, the WBC confirms that main event fighters are being tested by VADA—leaving Haney’s accusation hanging like a punch in mid-air. Is Garcia’s decision to skip year-round testing a red flag, or is Haney overreacting? Let’s spark a debate: Does a fighter’s choice to opt out of rigorous drug testing disqualify them from high-profile rematches? Share your thoughts below—this is one controversy that’s far from over.
